1,709 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Putney Financial Group LLC

Putney Financial Group LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,709 shares of the company’s stock, valued at approximately $127,000.

Other hedge funds have also recently bought and sold shares of the company. Strs Ohio lifted its stake in shares of GE HealthCare Technologies by 3.8% in the second quarter. Strs Ohio now owns 385,940 shares of the company’s stock valued at $28,587,000 after buying an additional 14,231 shares during the period. Atria Investments Inc grew its position in GE HealthCare Technologies by 17.3% in the second quarter. Atria Investments Inc now owns 48,934 shares of the company’s stock valued at $3,625,000 after acquiring an additional 7,215 shares during the period. Savvy Advisors Inc. increased its position in shares of GE HealthCare Technologies by 30.6% during the 2nd quarter. Savvy Advisors Inc. now owns 4,673 shares of the company’s stock worth $346,000 after purchasing an additional 1,094 shares in the last quarter. Assetmark Inc. increased its holdings in shares of GE HealthCare Technologies by 46.0% during the second quarter. Assetmark Inc. now owns 9,107 shares of the company’s stock worth $675,000 after buying an additional 2,868 shares in the last quarter. Finally, Arkadios Wealth Advisors increased its holdings in GE HealthCare Technologies by 43.4% during the 2nd quarter. Arkadios Wealth Advisors now owns 17,608 shares of the company’s stock valued at $1,304,000 after purchasing an additional 5,329 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $75.00 on Friday. The business’s 50 day moving average price is $75.10 and its two-hundred day moving average price is $72.91. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a market cap of $34.24 billion, a PE ratio of 15.50, a price-to-earnings-growth ratio of 2.95 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the company earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on GEHC shares. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday. Barclays assumed coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.